Proton beam therapy for medulloblastoma – Author’s reply - 04/05/16
Doi : 10.1016/S1470-2045(16)30061-4
Torunn I Yock a 
, Nancy J Tarbell a, Beow Y Yeap b, David H Ebb c, Elizabeth Weyman a, Bree R Eaton a, h, Nicole A Sherry d, Robin M Jones e, Shannon M MacDonald a, Margaret B Pulsifer f, Beverly Lavally c, Annah N Abrams g, Mary S Huang c, Karen J Marcus i
, Nancy J Tarbell a, Beow Y Yeap b, David H Ebb c, Elizabeth Weyman a, Bree R Eaton a, h, Nicole A Sherry d, Robin M Jones e, Shannon M MacDonald a, Margaret B Pulsifer f, Beverly Lavally c, Annah N Abrams g, Mary S Huang c, Karen J Marcus i a Department of Radiation Oncology, Massachusetts General Hospital, Boston, MA, USA
b Department of Medicine, Massachusetts General Hospital, Boston, MA, USA
c Department of Pediatric Oncology, Massachusetts General Hospital, Boston, MA, USA
d Department of Pediatric Endocrinology, Massachusetts General Hospital, Boston, MA, USA
e Department of Pediatric Neurology, Massachusetts General Hospital, Boston, MA, USA
f Department of Psychiatry, Massachusetts General Hospital, Boston, MA, USA
g Department of Child Psychiatry, Massachusetts General Hospital, Boston, MA, USA
h Winship Cancer Institute of Emory University, Atlanta, GA, USA
i Department of Radiation Oncology, Brigham and Women’s Hospital, Boston, MA, USA
El texto completo de este artículo está disponible en PDF.
© 2016
Elsevier Ltd. Reservados todos los derechos.
Vol 17 - N° 5
P. e174-e175 - mai 2016 Regresar al número
Artículo precedente
- Proton beam therapy for medulloblastoma
- Martin English, Richard G Grundy, Andrew Peet, Stephen Lowis, David Walker
- Neratinib after trastuzumab in patients with HER2-positive breast cancer
- Takahiro Hasegawa, Hajime Uno, Lee-Jen Wei
¿Ya suscrito a @@106933@@ revista ?